WO1991002530A1 - Accelerator for periodontal tissue regeneration - Google Patents

Accelerator for periodontal tissue regeneration Download PDF

Info

Publication number
WO1991002530A1
WO1991002530A1 PCT/JP1990/001066 JP9001066W WO9102530A1 WO 1991002530 A1 WO1991002530 A1 WO 1991002530A1 JP 9001066 W JP9001066 W JP 9001066W WO 9102530 A1 WO9102530 A1 WO 9102530A1
Authority
WO
WIPO (PCT)
Prior art keywords
acetyl
periodontal
periodontal tissue
tissue regeneration
accelerator
Prior art date
Application number
PCT/JP1990/001066
Other languages
English (en)
French (fr)
Japanese (ja)
Inventor
Naoki Matsuda
Kyoto Yamazaki
Masahiro Matsuura
Original Assignee
Sunstar Kabushiki Kaisha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sunstar Kabushiki Kaisha filed Critical Sunstar Kabushiki Kaisha
Publication of WO1991002530A1 publication Critical patent/WO1991002530A1/ja

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004Monosaccharides having only carbon, hydrogen and oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms

Definitions

  • the present invention relates to an agent used for regenerating a periodontal membrane destroyed by periodontitis and promoting adhesion between a normal root and connective tissue.
  • periodontitis has been treated mainly by mechanically removing plaque in periodontal pockets by scaling, etc., and in severe cases, by performing periodontal surgical treatment fi.
  • chemotherapy with antibiotics has recently been attempted.
  • these therapies are effective measures to stop the progression of periodontitis, they do not narrowly repair and regenerate broken periodontal tissue, and only improve clinical symptoms. It is due to the self-healing power of the living body.
  • Periodontal tissue is a structure not found in other tissues, in which hard tissue ⁇ (root) and ⁇ tissue (gingiva) adhere to each other through fibrous firm coupling through the periodontal ligament
  • hard tissue ⁇ (root) and ⁇ tissue (gingiva) adhere to each other through fibrous firm coupling through the periodontal ligament
  • epithelial cells on the gingival surface cover the destroyed part before the periodontal ligament regenerates (epidermal downgrowth). Only loose coupling between epithelial tracks and tooth roots occurs. As a result, the restoration and regeneration of the surrounding area is prolonged, and street meat regression occurs frequently.
  • the present invention relates to a periodontal tissue regenerating device having excellent safety, stability and efficacy.
  • the purpose is to provide crude drugs.
  • the present invention relates to N-acetyl-D-glucosamine, N-acetyl-D-galactosamine, N-acetyl-D-mannosamine, and an amino acid obtained by combining these amino sugars with each other.
  • An object of the present invention is to provide a periodontal tissue regenerating agent characterized by containing an N-acetylated amino sugar selected from the group consisting of glycose as an active ingredient.
  • N-acetylated amino sugars are disclosed in Japanese Patent Publication No. 58-119927 as an effective component of an oral composition for inhibiting the adhesion of plaque to teeth.
  • this there is no report that applied this in the treatment of periodontitis.
  • the present inventors have found that these N-acetylated amino sugars also have an effect of promoting periodontal tissue regeneration and are useful for treating periodontitis.
  • N-Acetyl-D-glucosamine used as an active ingredient in the present invention N-acetyl-D-galactosamine is the main component of chondroitin sulfate, which is the main component of chitin, a polysaccharide of the shells of insects and crustaceans, and exists in nature along with N-acetyl-D-mannosamine.
  • the N-acetyl-D-glucosamine oligomer hydrolyzes chitin, neutralizes and desalinates, and is isolated and purified by gel filtration.
  • N-Acetyl-D-galactosamine oligomers are isolated and purified by the gel-pass method after hydrolyzing and acetylating 1,4-polygalactosamine, in which D-galactosamine is mainly 1,4-linked. .
  • cytotoxicity to cultured human periodontal ligament cells is 10; ⁇ 9 / ⁇ ! ⁇ or more, and efficacy is observed between 10 and 1 0 0 / ⁇ ? / ⁇ shows no growth inhibition.
  • the periodontal tissue regeneration-promoting agent of the present invention contains an effective and non-toxic amount of the peracetylated amino sugar in a pharmaceutically acceptable carrier such as a solvent, Combined with tonicity agent, emulsifier, suspending agent, stabilizer To give an external preparation (eg, liquid, emulsion, gel).
  • a pharmaceutically acceptable carrier such as a solvent, Combined with tonicity agent, emulsifier, suspending agent, stabilizer
  • an external preparation eg, liquid, emulsion, gel.
  • Such a periodontal moth regeneration promoter of the present invention can be used by periodontal surgery, or by directly administering it to the ⁇ root after lubrication treatment ⁇ and to the detached gingival surface.
  • the dose can be appropriately determined depending on the condition to be treated and the condition, but usually, the concentration of the N-acetylated amino sugar is 10 to 1009 / lK i .0.01 to 0.01%).
  • the regeneration promoting effect was tested. The results are shown below.
  • Betapaiita tissue ⁇ for dish in periodontal ligament fibroblasts assembly ⁇ 3.0 1 0 4 were seeded ⁇ , after incubation for 1 day at at 37, various ⁇ - Asechi Le of Amino sugar and Origo sugars 1 The mixture was added at a ratio of 0, and further incubated at 37 for 2 days. The cells were then stripped from the petri dish with a 0.15% trypsin solution, and the number of cells was counted using a hemocytometer. As a control, the same test was performed without adding any sample.
  • Table 2 shows the number of cells grown in the Petri dish for each sample.
  • the gingival flap was repositioned, and suture and back protection was applied for one week.
  • the test site was sampled, a tissue specimen was prepared by a conventional method, and an eyepiece microphone was placed under a microscope.
  • the distance between each part was also measured using a mouthpiece and quantified according to the following criteria.
  • Table 3 shows the length of bone removal ⁇ 10 ⁇ .
  • N-acetyl-D-galactosamin and its trimer, N-acetyl-D-mannosamine, and N-acetyl-D-glucosamino trimer slightly inhibit epithelial downgrowth and also reduce On the other hand, it clearly showed a promoting effect on the fibrous adhesion rate.
  • N-acetylated amino sugars and oligosaccharides have excellent periodontal tissue regeneration promoting action.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Cosmetics (AREA)
PCT/JP1990/001066 1989-08-25 1990-08-22 Accelerator for periodontal tissue regeneration WO1991002530A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1/220031 1989-08-25
JP1220031A JPH0383927A (ja) 1989-08-25 1989-08-25 歯周組織再生促進剤

Publications (1)

Publication Number Publication Date
WO1991002530A1 true WO1991002530A1 (en) 1991-03-07

Family

ID=16744846

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP1990/001066 WO1991002530A1 (en) 1989-08-25 1990-08-22 Accelerator for periodontal tissue regeneration

Country Status (3)

Country Link
JP (1) JPH0383927A (zh)
CN (1) CN1052045A (zh)
WO (1) WO1991002530A1 (zh)

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5286480A (en) * 1992-06-29 1994-02-15 The Procter & Gamble Company Use of N-acetylated amino acid complexes in oral care compositions
US5362480A (en) * 1991-12-31 1994-11-08 Lever Brothers Company, Division Of Conopco, Inc. Oral hygiene compositions containing amino sugars as antiplaque agents
WO2004014398A1 (en) 2002-08-13 2004-02-19 Third Military Medical University, Chinese People's Liberation Army, P.R. Of China The use of n-acetyl-d-glucosamine for preparing medicines for urogenital tract infection’s treatment and prevention
US6992073B2 (en) 2001-02-28 2006-01-31 Third Military Medical University, Chinese People's Liberation Army Use of N-acetyl-D-glucosamine in the manufacture of a medicament for treating cervical erosion
US7345030B2 (en) 2003-03-27 2008-03-18 Third Military Medical University, Chinese People's Liberation Army, P.R. Of China Use of n-acetyl-d-aminoglycosamine in treatment of organ lesions related to toxicosis of drugs or chemicals
WO2011006263A1 (en) * 2009-07-17 2011-01-20 Klox Technologies Inc. Antibacterial oral composition
US8632822B2 (en) 2008-11-07 2014-01-21 Klox Technologies Inc. Combination of an oxidant and a photoactivator for the healing of wounds
US8986719B2 (en) 2005-11-09 2015-03-24 Klox Technologies Inc. Teeth whitening compositions and methods
US9655829B2 (en) 2012-09-14 2017-05-23 Valeant Pharmaceuticals International, Inc. Compositions and methods for teeth whitening
US10130706B2 (en) 2013-03-14 2018-11-20 Klox Technologies Inc. Biophotonic materials and uses thereof
US10207029B2 (en) 2014-04-01 2019-02-19 Klox Technologies Inc. Tissue filler compositions and methods of use
US10213373B2 (en) 2012-04-20 2019-02-26 Klox Technologies, Inc. Chromophore combinations for biophotonic uses
US10881736B2 (en) 2013-07-03 2021-01-05 Klox Technologies Inc. Biophotonic compositions comprising a chromophore and a gelling agent for treating wounds
US11116841B2 (en) 2012-04-20 2021-09-14 Klox Technologies Inc. Biophotonic compositions, kits and methods
US11419806B2 (en) * 2013-12-27 2022-08-23 Colgate-Palmolive Company Prebiotic oral care methods using a saccharide
US11421349B2 (en) 2014-10-31 2022-08-23 Klox Technologies Inc. Photoactivatable fibers and fabric media

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7018899B2 (ja) * 2016-05-26 2022-02-14 スリーエム イノベイティブ プロパティズ カンパニー 治療用歯科用ペースト並びに関連する方法及びキット

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5569506A (en) * 1978-11-16 1980-05-26 Sunstar Inc Composition for oral cavity application
JPS60142923A (ja) * 1983-12-28 1985-07-29 Lion Corp 歯周病薬
JPS62294607A (ja) * 1986-06-13 1987-12-22 Kanebo Ltd 口腔用組成物

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5569506A (en) * 1978-11-16 1980-05-26 Sunstar Inc Composition for oral cavity application
JPS60142923A (ja) * 1983-12-28 1985-07-29 Lion Corp 歯周病薬
JPS62294607A (ja) * 1986-06-13 1987-12-22 Kanebo Ltd 口腔用組成物

Cited By (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5362480A (en) * 1991-12-31 1994-11-08 Lever Brothers Company, Division Of Conopco, Inc. Oral hygiene compositions containing amino sugars as antiplaque agents
US5286480A (en) * 1992-06-29 1994-02-15 The Procter & Gamble Company Use of N-acetylated amino acid complexes in oral care compositions
US5358705A (en) * 1992-06-29 1994-10-25 The Procter & Gamble Company Use of N-acetylated amino acid complexes in oral care compositions
US6992073B2 (en) 2001-02-28 2006-01-31 Third Military Medical University, Chinese People's Liberation Army Use of N-acetyl-D-glucosamine in the manufacture of a medicament for treating cervical erosion
WO2004014398A1 (en) 2002-08-13 2004-02-19 Third Military Medical University, Chinese People's Liberation Army, P.R. Of China The use of n-acetyl-d-glucosamine for preparing medicines for urogenital tract infection’s treatment and prevention
US7345030B2 (en) 2003-03-27 2008-03-18 Third Military Medical University, Chinese People's Liberation Army, P.R. Of China Use of n-acetyl-d-aminoglycosamine in treatment of organ lesions related to toxicosis of drugs or chemicals
US8986719B2 (en) 2005-11-09 2015-03-24 Klox Technologies Inc. Teeth whitening compositions and methods
US8658219B2 (en) 2008-11-07 2014-02-25 Klox Technologies Inc. Oxidatitive photoactivated skin rejeuvenation composition comprising hyaluronic acid, glucosamine, or allantoin
US11020609B2 (en) 2008-11-07 2021-06-01 Klox Technologies Inc. Methods and compositions for treatment of pigmented lesions
US11691025B2 (en) 2008-11-07 2023-07-04 Klox Technologies Inc. Methods and compositions for reversing or mitigating skin aging
US10149985B2 (en) 2008-11-07 2018-12-11 Klox Technologies Inc. Methods and compositions for treating rosacea
US8911791B2 (en) 2008-11-07 2014-12-16 Klox Technologies Inc. Method for acne treatment using an oxidative-photoactivated composition
US8974833B2 (en) 2008-11-07 2015-03-10 Klox Technologies Inc. Combination of an oxidant and a photoactivator for the healing of wounds
US8986745B2 (en) 2008-11-07 2015-03-24 Klox Technologies Inc. Oxidatitive photoactivated skin rejeuvenation composition comprising hyaluronic acid, glucosamine, or allantoin
US8637086B2 (en) 2008-11-07 2014-01-28 Klox Technologies Inc. Method for acne treatment using an oxidative-photoactivated composition
US8632822B2 (en) 2008-11-07 2014-01-21 Klox Technologies Inc. Combination of an oxidant and a photoactivator for the healing of wounds
US9375446B2 (en) 2008-11-07 2016-06-28 Klox Technologies Inc. Oxidatitive photoactivated skin rejeuvenation composition comprising hyaluronic acid, glucosamine, or allantoin
US10758744B2 (en) 2008-11-07 2020-09-01 Klox Technologies Inc. Combination of an oxidant and a photoactivator for the wounds
US9597349B2 (en) 2008-11-07 2017-03-21 Klox Technologies Inc. Combination of an oxidant and a photoactivator for the healing of wounds
US10485986B2 (en) 2008-11-07 2019-11-26 Klox Technologies Inc. Methods and compositions for treatment of pigmented lesions
US10384072B2 (en) 2008-11-07 2019-08-20 Klox Technologies Inc. Combination of an oxidant and a photoactivator for the healing of wounds
US8685466B2 (en) 2009-07-17 2014-04-01 Klox Technologies Inc. Combination of an oxidant, a photosensitizer and a wound healing agent for oral disinfection and treatment of oral disease
US10322179B2 (en) 2009-07-17 2019-06-18 Klox Technologies Inc. Combination of an oxidant, a photosensitizer and a wound healing agent for oral disinfection and treatment of oral disease
WO2011006263A1 (en) * 2009-07-17 2011-01-20 Klox Technologies Inc. Antibacterial oral composition
US10471147B2 (en) 2009-07-17 2019-11-12 Klox Technologies Inc. Combination of an oxidant, a photosensitizer and a wound healing agent for oral disinfection and treatment of oral disease
US9603929B2 (en) 2009-07-17 2017-03-28 Klox Technologies Inc. Combination of an oxidant, a photosensitizer and a wound healing agent for oral disinfecton and treatment of oral disease
EA025022B1 (ru) * 2009-07-17 2016-11-30 Клокс Текнолоджиз Инк. Антибактериальная композиция для ротовой полости
US11141482B2 (en) 2009-07-17 2021-10-12 Klox Technologies Inc. Combination of an oxidant, a photosensitizer and a wound healing agent for oral disinfection and treatment of oral disease
US8986746B2 (en) 2009-07-17 2015-03-24 Klox Technologies Inc. Combination of an oxidant, a photosensitizer and a wound healing agent for oral disinfection and treatment of oral disease
US11116841B2 (en) 2012-04-20 2021-09-14 Klox Technologies Inc. Biophotonic compositions, kits and methods
US11723854B2 (en) 2012-04-20 2023-08-15 Fle International S.R.L. Biophotonic compositions and methods for providing biophotonic treatment
US10213373B2 (en) 2012-04-20 2019-02-26 Klox Technologies, Inc. Chromophore combinations for biophotonic uses
US10376455B2 (en) 2012-04-20 2019-08-13 Klox Technologies Inc. Biophotonic compositions and methods for providing biophotonic treatment
US11331257B2 (en) 2012-04-20 2022-05-17 Klox Technologies Inc. Biophotonic compositions and methods for providing biophotonic treatment
US9655829B2 (en) 2012-09-14 2017-05-23 Valeant Pharmaceuticals International, Inc. Compositions and methods for teeth whitening
US11324823B2 (en) 2013-03-14 2022-05-10 Klox Technologies Inc. Biophotonic materials and uses thereof
US10130706B2 (en) 2013-03-14 2018-11-20 Klox Technologies Inc. Biophotonic materials and uses thereof
US10881736B2 (en) 2013-07-03 2021-01-05 Klox Technologies Inc. Biophotonic compositions comprising a chromophore and a gelling agent for treating wounds
US11419806B2 (en) * 2013-12-27 2022-08-23 Colgate-Palmolive Company Prebiotic oral care methods using a saccharide
US10772990B2 (en) 2014-04-01 2020-09-15 Klox Technologies Inc. Tissue filler compositions and methods of use
US10207029B2 (en) 2014-04-01 2019-02-19 Klox Technologies Inc. Tissue filler compositions and methods of use
US11421349B2 (en) 2014-10-31 2022-08-23 Klox Technologies Inc. Photoactivatable fibers and fabric media

Also Published As

Publication number Publication date
JPH0383927A (ja) 1991-04-09
CN1052045A (zh) 1991-06-12

Similar Documents

Publication Publication Date Title
WO1991002530A1 (en) Accelerator for periodontal tissue regeneration
US4442125A (en) Process for detaching or preventing attachment of microorganisms to a surface
Listgarten et al. Electron microscopic evidence of a cellular attachment between junctional epithelium and dental calculus
Pitts et al. Investigation of the role of endotoxin in periapical inflammation
Davis et al. Periapical and intracanal healing following incomplete root canal fillings in dogs
Warfvinge et al. Healing capacity of human and monkey dental pulps following experimentally‐induced pulpitis
Dahlén et al. Histological and histochemical study of the influence of lipopolysaccharide extracted from Fusobacterium nucleatum on the periapical tissues in the monkey Macaca fascicularis
Cox et al. Healing sequence in capped inflamed dental pulps of Rhesus monkeys (Macaca mulatta)
Wikesjö et al. Periodontal repair in dogs: effect of root surface treatment with stannous fluoride or citric acid on root resorption
Nasjleti et al. Replantation of mature teeth without endodontics in monkeys
Wirthlin et al. Biologic preparation of diseased root surfaces
Fujikawa et al. The effect of retained subgingival calculus on healing after flap surgery
Steinberg et al. Extravascular clot formation and platelet activation on variously treated root surfaces
Koide et al. Inhibition of experimental bone resorption and osteoclast formation and survival by 2-aminoethanesulphonic acid
Şen et al. Morphologic effects on L929 fibroblasts of titanium tetrafluoride application
KR20190087835A (ko) Cpne7의 치주인대 재생 용도
Ryder Histological and ultrastructural characteristics of the periodontal syndrome in the rice rat: I. General light microscopic observations and ultrastructural observations of initial inflammatory changes
CN109966315B (zh) 一种用于牙齿保护的组合物
JPH0597697A (ja) 歯槽骨再生剤
JPS60142923A (ja) 歯周病薬
JPH06256132A (ja) 覆髄剤
JP3721400B2 (ja) 組織再生剤
JPH04134035A (ja) 歯周組織再生促進用薬剤および材料
RU2330645C2 (ru) Способ лечения пародонтита
EP3407899B1 (de) Immunprophylaxe bei rezidivierenden bakteriellen infektionen

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): CA JP KR US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB IT LU NL SE

NENP Non-entry into the national phase

Ref country code: CA